TOP STORIES

• ACADEMIA Mismatch Found for 10% of ACR Data Between Papers, Patient Records: SMART Study
  November 1, 2013

• BUSINESS Takeda 1st Half Sales Rise 5.3% on New Portfolio, Weaker Yen
  November 1, 2013

• REGULATORY New CSIMC Healthcare Rep Nakagawa Says Against Perpetuation of Premium
  October 31, 2013

• ORGANIZATION PhRMA Makes Yet Another Case for Perpetuation of New Drug Premium
  October 31, 2013

• REGULATORY Generic Use for Anti-Allergic Agents Jumps after Pilot Leaflet Project: Kyokai Kenpo
  October 30, 2013

• REGULATORY 1st Committee Backs Japan Tobacco’s Hyperphosphatemia Treatment
  October 30, 2013

• ACADEMIA Beta Blockers “Inferior to Other Drugs,” Will Not Be Recommended as 1st–Line Treatments in New Hypertension GL
  October 29, 2013

• ORGANIZATION Generic Makers to Jointly Outsource GMP Inspections on Drug Substance Suppliers; Pilot to Begin by March
  October 28, 2013

• BUSINESS Teva’s Global Medical Director Says Biosimilars Can Cut Medical Costs
  October 25, 2013

• REGULATORY Regulatory Reform Council to Convene Public Discussion on Expansion of “Mixed Healthcare” on November 28
  October 25, 2013

• REGULATORY Diovan Panel Should Question 4 Key Figures to Dig into Scandal Further: Expert Member
  October 24, 2013

• REGULATORY MOF Demands Hefty Price Cuts for Long-Listed Products, Skeptical about Premium
  October 23, 2013

• BUSINESS Swiss Novartis Sees 22% Plunge in January-September Diovan Sales
  October 23, 2013

• ORGANIZATION No Clear Violation of Fair Competition Code in Diovan Case: Maker FTC Exec
  October 22, 2013

• BUSINESS Wholesalers’ Sluggish Price Settlement Rate Could Mar Reliability of Market Price Survey
  October 22, 2013

• ORGANIZATION JPMA Will Announce Response to Violation of PAL by Mitsubishi Tanabe in Near Future: Director General Goto
  October 21, 2013

• REGULATORY Ex-Health Minister Nagatsuma Eyes Unsworn Diet Testimony by Ex-Novartis Employee on Diovan Scandal
  October 18, 2013

• REGULATORY CSIMC Pricing Subcommittee OKs Indicator to Gauge Reasonableness of Premium’s Perpetuation
  October 17, 2013

• BUSINESS Gilead to Fully Enter Japan, File for Approval for Hepatitis C Treatment Sofosbuvir in 2014: President
  October 16, 2013

• BUSINESS Once-Weekly DPP-4 Inhibitors of MSD, Takeda to Bring New Dimension to Packed Market
  October 15, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 211
• 212
• 213
• 214
• 215
• 216
• 217
• 218
• 219
• …
• Next ›
• 最終 »